被忽视的热带疾病诊断市场研究报告按诊断方法（血清学检测、分子诊断、显微镜检查、免疫测定）、按疾病类型（淋巴丝虫病、血吸虫病、麻风病、查加斯病、登革热）、按最终用户（医院、诊断实验室、研究机构、公共卫生组织）、按技术（PCR 技术、快速检测试剂盒、下一代测序、自动化）分析仪）和按地区（北美、欧洲、南美、亚太地区、中东和非洲）- 到 2034 年的预测
ID: MRFR/HC/32183-HCR | 100 Pages | Author: Rahul Gotadki| July 2025
| Report Attribute/Metric | Details |
| Market Size 2024 | 8.75 (USD Billion) |
| Market Size 2025 | 9.20 (USD Billion) |
| Market Size 2034 | 14.38 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.09 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Siemens Healthineers, Merck, Becton Dickinson, Hologic, BioRad Laboratories, Qiagen, Cepheid, Thermo Fisher Scientific, Abbott, Agilent Technologies, Johnson and Johnson, Roche, Novartis, Deloitte, GlaxoSmithKline |
| Segments Covered | Diagnostic Method, Disease Type, End User, Technology, Regional |
| Key Market Opportunities | Increased funding for research initiatives, Technological advancements in diagnostic tools, Rising awareness of neglected diseases, Collaborations with global health organizations, Expanding access to healthcare infrastructure |
| Key Market Dynamics | Rising prevalence of NTDs, Increased funding and partnerships, Technological advancements in diagnostics, Growing awareness and education, Regulatory support and initiatives |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Neglected Tropical Diseases Diagnosis Market is projected to be valued at 14.38 USD Billion by 2034.
The expected CAGR for the Neglected Tropical Diseases Diagnosis Market from 2025 to 2034 is 5.09%.
The Immunological Assays diagnostic method is projected to have the highest market value, reaching 4.5 USD Billion in 2032.
North America is expected to have the largest market share, valued at 3.25 USD Billion in 2032.
The estimated market value of Molecular Diagnostics is projected to be 3.3 USD Billion in 2032.
Key players include Siemens Healthineers, Merck, Becton Dickinson, Hologic, and BioRad Laboratories.
The market size for Serological Testing is expected to be approximately 2.0 USD Billion in 2024.
The APAC region is projected to show significant growth, with a market size of 3.5 USD Billion by 2032.
The market size for the Microscopy diagnostic method is expected to be around 1.35 USD Billion in 2024.
The market faces challenges such as limited funding for diagnostics and underreporting of neglected tropical diseases.
Comments
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
